Jamshid Tanha
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Targeting the NLRP3 inflammasome with antibody-based therapeutics for chronic neurodegenerative diseases.
Journal: Expert opinion on therapeutic targets
Published: May 09, 2026
Multifunctional ACE2-nanobody fusion design for pan-specific neutralization and cardiovascular protection in SARS coronavirus infection.
Journal: Antimicrobial agents and chemotherapy
Published: March 23, 2026
A Safe and Accessible Cell-Based Spike-ACE2 Binding Assay for Evaluating SARS-CoV-2 Neutralization Activity in Biological Samples Using Flow Cytometry.
Journal: Methods and protocols
Published: July 15, 2025
Editorial: Engineering antibodies and bacteriophages to manage and diagnose microbial infections.
Journal: Frontiers in microbiology
Published: January 27, 2025
Optimization of synthetic human VH affinity and solubility through in vitro affinity maturation and minimal camelization.
Journal: Protein science : a publication of the Protein Society
Published: November 27, 2024
Modifying the glycosylation profile of SARS-CoV-2 spike-based subunit vaccines alters focusing of the humoral immune response in a mouse model.
Journal: Communications medicine
Published: July 10, 2024
Sequence tolerance of immunoglobulin variable domain framework regions to noncanonical intradomain disulfide linkages.
Journal: The Journal of biological chemistry
Published: June 15, 2023
Influence of variant-specific mutations, temperature and pH on conformations of a large set of SARS-CoV-2 spike trimer vaccine antigen candidates.
Journal: Scientific reports
Published: April 12, 2023
Corrigendum: Structure-guided design of a potent Clostridioides difficile toxin A inhibitor.
Journal: Frontiers in microbiology
Published: February 16, 2023
Last Updated: 09/26/2026